HomeStock ScreenerTrimurthiIntrinsic Value

Trimurthi Intrinsic Value

Trimurthi (NOVELIX) median intrinsic value is ₹17.89 from 3 valuation models (range ₹12–₹34), vs current price ₹59.62 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse Trimurthi annual reports for revenue, profit, balance sheet and cash flow data.

Current Stock Price
₹59.62
Primary Intrinsic Value
₹11.92
Market Cap
₹47.7 Cr
-70.0% Downside
Median Value
₹17.89
Value Range
₹12 - ₹34
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

NOVELIX Valuation Methods Summary — DCF, Graham Number & P/E

Trimurthi intrinsic value across 3 models vs current price ₹59.62 — upside/downside and value range per method. For current market price and key ratios, visit Trimurthi stock price NSE.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹11.92 ₹10.73 - ₹13.11 -80.0% Book Value/Share: ₹10.00, P/B: 1.0x
Revenue Multiple Method revenue ₹17.89 ₹16.10 - ₹19.68 -70.0% Revenue/Share: ₹5.00, P/S: 0.8x
Simple DCF (5Y) dcf ₹33.96 ₹27.17 - ₹40.75 -43.0% CF Growth: 15.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

NOVELIX Intrinsic Value vs Market Price — All Valuation Models

Trimurthi fair value range ₹12–₹34 vs current market price ₹59.62 across 3 valuation models. Also explore NOVELIX price movement history to track price trends across different timeframes.

NOVELIX Intrinsic Value Analysis — Undervalued or Overvalued?

Trimurthi median intrinsic value ₹17.89, current price ₹59.62 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of NOVELIX?

Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Trimurthi (NOVELIX) is ₹17.89 (median value). With the current market price of ₹59.62, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹11.92 to ₹33.96, indicating ₹11.92 - ₹33.96.

Is NOVELIX undervalued or overvalued?

Based on our multi-method analysis, Trimurthi (NOVELIX) appears to be trading above calculated value by approximately 70.0%.

NOVELIX Financial Health — Key Ratios vs Industry Benchmarks

Trimurthi financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Operating Margin -15.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.44x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

NOVELIX Cash Flow Quality — Operating & Free Cash Flow

Trimurthi operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2022 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10
March 2021 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10
March 2020 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10
March 2019 ₹-1 Cr ₹-1 Cr Negative Cash Flow 3/10
March 2018 ₹0 Cr ₹-1 Cr Negative Cash Flow 3/10